Deirdre Cunnane
General Counsel/Chief Operating Officer at Omega Funds | Cambridge, Massachusetts, United States
Deirdre Cunnane’s Email & Phone Number
VerifiedFree account · No credit card · 5 profiles/month
General Counsel/Chief Operating Officer at Omega Funds in October 2019 - Present
Chief Legal Officer at Catabasis Pharmaceuticals, Inc. in February 2018 - October 2019
General Counsel at Catabasis Pharmaceuticals, Inc. in November 2015 - February 2018
General Counsel at Advanced Technology Ventures in January 2006 - November 2015
Supervising Attorney, Harvard Law Entrepreneurship Project at Harvard Law School in November 2014 - October 2015
Director, Investment Officer at Bank of America in April 2004 - December 2005
Deputy General Counsel at BancBoston Capital in January 1998 - April 2004
Partner at Goodwin Procter in January 1989 - January 1998
Summer Associate at Burns and Levinson in June 1988 - August 1988
Boston College Law School, JD, October 1986 to October 1989
Boston College, BS, October 1983 to October 1987
Omega Funds is a leading international investment firm that creates and invests in life sciences companies that target the world’s most urgent medical needs. Ω is the last letter of the Greek alphabet. Our investment process starts by focusing on the end goal – delivering impactful medicines to patients. We aim to invest in exceptional founders and entrepreneurs and impactful products and platforms across multiple therapeutic areas, including oncology, immunology, rare diseases, precision medicine and others. Early seed or late stage public financing. Large markets or rare diseases. Established targets or novel technologies. We are guided by our conviction in people, products and breakthrough ideas, not by conventional categories. Our investments span a variety of instruments from early venture rounds, to late-stage investing, direct secondary transactions, as well as company founding and creation. Omega Funds has raised approximately $2.5 billion since its inception in 2004 and is headquartered in Boston, Massachusetts, USA. Please be mindful of scams presented by unauthorized individuals regarding fictitious positions, job offers and other misrepresentations. We do not ask candidates to provide sensitive identifiable information via email. If a person claiming to be an Omega recruiter reaches out to you regarding a job opportunity, please report it to our team by emailing [email protected] with the details.
Discover more about Omega Funds
Principal at Omega Funds
Principal at Omega Funds
(January 2025 – Present)
Life Science Investors
Omega Funds at Omega Funds
(January 2004 – Present)
Formerly Executive Vice President at AstraZeneca helping push the boundaries of science to deliver life-changing medicines to patients
Board Member at The Francis Crick Institute
(Jan 2021 – Present)
Managing Director at Omega Funds
Board Observer at ARTBIO
(Jun 2022 – Present)
Partner at Omega Funds
Current Board Seats:
-Callio Therapeutics (USA, private)
-Sophia Genetics (Switzerland, NASDAQ listed), Independent Board Director, member of the Remuneration Committee
-Anaconda Brain (Spain, private), Board observer
Prior Board of Director experience:
-FoRx (Switzerland, p...
Vice President at Omega Funds
Vice President at Omega Funds
(Jan 2025 – Present)
What is Deirdre Cunnane email address?
Email Deirdre Cunnane at [email protected] and [email protected]. This email is the most updated Deirdre Cunnane's email found in 2026.
How to contact Deirdre Cunnane?
To contact Deirdre Cunnane send an email to [email protected] or [email protected]. (updated on September 18, 2025)
What company does Deirdre Cunnane work for?
Deirdre Cunnane works for Omega Funds.
What is Deirdre Cunnane's role at Omega Funds?
Deirdre Cunnane is General Counsel/Chief Operating Officer
What industry does Deirdre Cunnane work in?
Deirdre Cunnane works in the Venture Capital & Private Equity industry.
